Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Stanford University
Stanford University
Swiss Cancer Institute
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey